ARCHIVES

Report calls for stronger peer review, prioritization for cancer clinical trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 23 | June 10, 2005

Download PDF Visit The Full Archive

Related Articles

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

NCAB Delays Decision On Organ Site Program Until May Meeting

February 12, 1982

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976